Term
MHC I: antigen pres to cells |
|
Definition
1) protesome digests intracellular protein products; 2) TAP transported digested protein products to ER & loads them to MHC I; 3) Golgi MHC I + peptide complex go through vesicular traff. via golgi; 4) MHC I peptide presented at cell surface |
|
|
Term
MHC II antigen pres to cells |
|
Definition
1) MHC II alpha + beta chains made in ER; 2) MHC II bound to invariant chain(w/o invariant chain MHC II will not leave ER); 3) MHC II + invariant chain traff to Golgi; 4) external antigens endocytosed, usually by receptor mediated endocytosis; 5) MHC II vesicles fuse with late endosomes becoming acidifed causing degradation of invariant chain leaving Clip; 6) HLA-DM catalyzes entire Clip peptide |
|
|
Term
MHC I interacting partner |
|
Definition
|
|
Term
MHC II interacting partner |
|
Definition
|
|
Term
MHC I: source of peptides |
|
Definition
internal proteins, usually degraded by protesome |
|
|
Term
MHC I: average peptide length |
|
Definition
|
|
Term
MHC I: Tissue distribution |
|
Definition
Almost all nucleated cells |
|
|
Term
|
Definition
1 chain (+ beta 2 microglobin) |
|
|
Term
MHC II: source of peptides |
|
Definition
extracellular space, inmportant in endocytosis |
|
|
Term
MHC II: average peptide length |
|
Definition
|
|
Term
|
Definition
|
|
Term
what is cross presentation? |
|
Definition
a rare process found usually in dendritic cells. Means there is an alternate Class I pathway, have leaky endosomes allow extracellular peptides to be presented on MHC I. Alternate MHC II class pathway transported to early endosomes where encounter intracellular peptides. |
|
|
Term
|
Definition
Like MHC I but binds and presents hydrophobic antigens, e.g. mycobacterial glycoproteins and other lipids |
|
|
Term
|
Definition
Like MHC II, but not polymorphic, helps catalyze CLIP and peptide exchange in late endosome |
|
|
Term
Naive T cell activation: where? |
|
Definition
secondary lymphoid tissue |
|
|
Term
drug classes that inhibit T cell signaling |
|
Definition
1) Tacrolimus binds intracellular partner-> inhibits calcineurin 2) Rapamycin inhibits MTOR blocks AP1 activation, inhibits AP1 signal transduction (glucocorticoids also block AP1) 3) Daclizumab-anti-IL2 receptor (humanized mouse antibody) |
|
|
Term
|
Definition
promotes killing of intracellular pathogens |
|
|
Term
Th1: important developmental cytokines and their sources |
|
Definition
|
|
Term
Th1: cytokines produced by T cell subset |
|
Definition
IFN-gamma (important for macrophages eating and digesting) |
|
|
Term
Th1: transcription factor regulating differentiation |
|
Definition
|
|
Term
|
Definition
stimulate B cells to produce antibody. IgE against multicellular extracellular parasites and allergy |
|
|
Term
Th2: important developmental cytokines and sources |
|
Definition
IL-4, most important for Th2 development |
|
|
Term
Th2: cytokines produced by T cell subset |
|
Definition
|
|
Term
Th2: trans factor regulating dif |
|
Definition
|
|
Term
|
Definition
involved in fighting some bacterial and fungal infections (involved in autoimmune processes) |
|
|
Term
Th17: import deveo cytokines and sources |
|
Definition
|
|
Term
Th17: cytokines produced by T cell subset |
|
Definition
|
|
Term
Th 17: transcription factor reg diff |
|
Definition
ROR gamma T (orphan trans factor) |
|
|
Term
|
Definition
provide t cell help (critical to B cell maturation, found in follicles) |
|
|
Term
T foll important deveo cytokines and their sources |
|
Definition
|
|
Term
T follicular cytokines produced by T cell subset |
|
Definition
|
|
Term
|
Definition
|
|
Term
pathogens targeted by CD8 cytotoxic t cells |
|
Definition
intracellular-viruses, cytokines: INF gamma, TNF alpha and TNF beta |
|
|
Term
CD8 T cell cytokines: Inf gamma, tnf alpha, tnf beta |
|
Definition
|
|
Term
mechanisms of cytotoxicity (CD8) |
|
Definition
1) Fas, fas ligand (nonsecrotory lysis); 2) Granzyme perforin, secretory lysis |
|
|
Term
|
Definition
1) catabolism of internal organelles; 2) Fragment DNA; 3) membrane blebbing |
|
|